Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Barrett's esophagus" and "Society guideline links: Esophageal cancer" and "Society guideline links: Subacute and chronic cough in adults".)
International
●World Gastroenterology Organisation (WGO): Global guidelines on GERD – Global perspective on gastroesophageal reflux disease (2017)
Canada
●Choosing Wisely Canada: Don't maintain long term Proton Pump Inhibitor (PPI) therapy for gastrointestinal symptoms without an attempt to stop/reduce PPI at least once per year in most patients (2021)
United States
●American Gastroenterological Association (AGA): Expert review – Clinical practice update on the diagnosis and management of extraesophageal gastroesophageal reflux disease (2023)
●AGA: Expert review – Clinical practice update on the personalized approach to the evaluation and management of GERD (2022)
●Society of American Gastrointestinal and Endoscopic Surgery (SAGES), American Society for Gastrointestinal Endoscopy (ASGE), American Society for Metabolic and Bariatric Surgery (ASMBS), European Association for Endoscopic Surgery (EAES), Society for Surgery of the Alimentary Tract (SSAT), and The Society of Thoracic Surgeons (STS): Multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD) (2022)
●American College of Gastroenterology (ACG): Guidelines for the diagnosis and management of gastroesophageal reflux disease (2021)
●SAGES: Guidelines for the surgical treatment of gastroesophageal reflux disease (GERD) (2021)
●AGA: Clinical practice update – Expert review on the functional lumen imaging probe for the management of esophageal disorders (2017)
●AGA: Clinical practice update – Expert review and best practice advice on the risks and benefits of long-term use of proton pump inhibitors (2017)
●ASGE: The role of endoscopy in the management of GERD (2015)
Europe
●Society of American Gastrointestinal and Endoscopic Surgery (SAGES), American Society for Gastrointestinal Endoscopy (ASGE), American Society for Metabolic and Bariatric Surgery (ASMBS), European Association for Endoscopic Surgery (EAES), Society for Surgery of the Alimentary Tract (SSAT), and The Society of Thoracic Surgeons (STS): Multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD) (2022)
●EAES: Recommendations for the management of gastroesophageal reflux disease (2014)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Interventional procedures guidance on endoluminal gastroplication for gastro-oesophageal reflux disease (2023)
●NICE: Interventional procedures guidance on laparoscopic insertion of a magnetic ring for gastro-oesophageal reflux disease (2023)
●British Society of Gastroenterology (BSG): Guidelines for oesophageal manometry and oesophageal reflux monitoring (2019)
●NICE: Clinical guideline on gastro-oesophageal reflux disease and dyspepsia in adults – Investigation and management (2014, updated 2019)
●NICE: Interventional procedures guidance on electrical stimulation of the lower oesophageal sphincter for treating gastro-oesophageal reflux disease (2015)
●NICE: Interventional procedures guidance on endoscopic radiofrequency ablation for gastro-oesophageal reflux disease (2013)
Australia–New Zealand
●Choosing Wisely Australia: Do not continue prescribing long term proton pump inhibitor (PPI) medication to patients without attempting to reduce the medication down to the lowest effective dose or cease the therapy altogether (2016)
●Choosing Wisely Australia: Don't use proton pump inhibitors (PPIs) long term in patients with uncomplicated disease without regular attempts at reducing dose or ceasing (2015)
Japan
●[In English] Japanese Society of Gastroenterology (JSGE): Evidence-based clinical practice guidelines for gastroesophageal reflux disease (GERD) (2021)
●[In Japanese] JSGE: Guidelines on gastroesophageal reflux disease (GERD) (2021)
